DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Shares Acquired by Crossmark Global Holdings Inc.

Crossmark Global Holdings Inc. lifted its position in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAYGet Rating) by 4.0% during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 18,007 shares of the medical instruments supplier’s stock after purchasing an additional 700 shares during the period. Crossmark Global Holdings Inc.’s holdings in DENTSPLY SIRONA were worth $510,000 as of its most recent SEC filing.

A number of other institutional investors have also made changes to their positions in the company. Vanguard Group Inc. lifted its position in shares of DENTSPLY SIRONA by 2.0% during the first quarter. Vanguard Group Inc. now owns 24,333,490 shares of the medical instruments supplier’s stock worth $1,197,694,000 after purchasing an additional 477,563 shares in the last quarter. Artisan Partners Limited Partnership increased its stake in shares of DENTSPLY SIRONA by 9.3% in the second quarter. Artisan Partners Limited Partnership now owns 12,758,726 shares of the medical instruments supplier’s stock worth $455,869,000 after buying an additional 1,089,244 shares during the last quarter. Price T Rowe Associates Inc. MD increased its stake in shares of DENTSPLY SIRONA by 10.0% in the second quarter. Price T Rowe Associates Inc. MD now owns 9,987,997 shares of the medical instruments supplier’s stock worth $356,871,000 after buying an additional 905,001 shares during the last quarter. Nuance Investments LLC increased its stake in shares of DENTSPLY SIRONA by 356.3% in the second quarter. Nuance Investments LLC now owns 9,051,338 shares of the medical instruments supplier’s stock worth $323,404,000 after buying an additional 7,067,751 shares during the last quarter. Finally, Wellington Management Group LLP increased its stake in shares of DENTSPLY SIRONA by 83.1% in the first quarter. Wellington Management Group LLP now owns 5,502,424 shares of the medical instruments supplier’s stock worth $270,829,000 after buying an additional 2,497,773 shares during the last quarter. 98.52% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

A number of analysts recently issued reports on XRAY shares. The Goldman Sachs Group dropped their price target on shares of DENTSPLY SIRONA from $41.00 to $34.00 and set a “neutral” rating for the company in a research note on Wednesday, November 16th. Robert W. Baird dropped their price target on shares of DENTSPLY SIRONA to $32.00 in a research note on Thursday, November 17th. StockNews.com started coverage on shares of DENTSPLY SIRONA in a research note on Wednesday, October 12th. They issued a “hold” rating for the company. William Blair upgraded shares of DENTSPLY SIRONA from an “underperform” rating to a “market perform” rating in a research note on Wednesday, January 11th. Finally, TheStreet lowered shares of DENTSPLY SIRONA from a “c” rating to a “d” rating in a research note on Monday, November 14th. Seven research analysts have rated the stock with a hold rating and three have issued a buy rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus price target of $40.70.

DENTSPLY SIRONA Trading Up 1.0 %

DENTSPLY SIRONA stock opened at $36.97 on Monday. The company has a 50-day simple moving average of $32.15 and a 200-day simple moving average of $32.37. The company has a debt-to-equity ratio of 0.48, a quick ratio of 1.04 and a current ratio of 1.50. DENTSPLY SIRONA Inc. has a one year low of $26.48 and a one year high of $58.70.

DENTSPLY SIRONA (NASDAQ:XRAYGet Rating) last released its quarterly earnings results on Monday, November 14th. The medical instruments supplier reported $0.41 EPS for the quarter, missing the consensus estimate of $0.59 by ($0.18). The firm had revenue of $947.00 million for the quarter, compared to the consensus estimate of $1.01 billion. DENTSPLY SIRONA had a positive return on equity of 9.63% and a negative net margin of 20.81%. The firm’s revenue was down 8.9% on a year-over-year basis. During the same quarter in the prior year, the company posted $0.68 EPS. On average, sell-side analysts forecast that DENTSPLY SIRONA Inc. will post 1.96 EPS for the current year.

DENTSPLY SIRONA Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Friday, January 13th. Stockholders of record on Friday, December 30th were given a dividend of $0.125 per share. The ex-dividend date of this dividend was Thursday, December 29th. This represents a $0.50 annualized dividend and a dividend yield of 1.35%.

DENTSPLY SIRONA Company Profile

(Get Rating)

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies for professional dental market worldwide. The company operates through two segments, Technologies & Equipment, and Consumables. The Technologies & Equipment segment provides dental equipment, such as treatment centers, imaging equipment, motorized dental handpieces, and other instruments for dental practitioners and specialists; dental CAD/CAM technologies for dental offices to support various digital dental procedures, including dental restorations; dentist-directed clear aligner solutions, SureSmile, and direct-to-consumer clear aligner solutions, as well as high frequency vibration technology device; implants; and urology catheters and other healthcare-related consumable products.

Featured Articles

Institutional Ownership by Quarter for DENTSPLY SIRONA (NASDAQ:XRAY)

Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.